Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's High Court on Wednesday gave Pfizer permission to take the case to the Court of Appeal. Pfizer and its German partner BioNTech sued Moderna in London in September 2022,

Health Canada approved Pfizer-BioNTech’s updated COVID-19 vaccine on Tuesday, marking its third authorization of vaccine formulations that protect against the most recently circulating variants of the virus.

After years of long lines and occasional shortages, more Americans are opting not to get the updated COVID-19 vaccine this year, according to a new national survey.

A multimillion-pound legal battle between rival developers of Covid-19 jabs over vaccine technology patents is set to continue at the Court of Appeal. In July, a High Court judge delivered a mixed ruling in the long-running dispute that has pitted pharmaceutical giant Pfizer and drug manufacturer BioNTech against vaccine maker Moderna.

Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

On Aug. 22, the U.S. Food and Drug Administration announced the approval of a new Novavax COVID vaccine, as well as updated versions of the Pfizer-BioNTech and Moderna vaccines. According to NPR, this latest vaccine is already being distributed and administered across the country.

Centers for Disease Control and Prevention Director Mandy Cohen explains why another new round of COVID-19 shots is becoming available.

Pfizer Canada says Health Canada has approved its updated COVID-19 vaccine that protects against one of the most recently circulating variants of the virus.